Clinical Trial Update: Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Cytogam administration in abdominal organ transplant recipients at high risk for cytomegalovirus infection; results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Disease

Drugs mentioned

• CytoGam (Cytomegalovirus immune globulin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cytomegalovirus Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-10-04